RT Journal Article
T1 Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies
A1 Amigo Basilio, Marta
A1 Álvarez González, Covadonga
A1 Cobo Vázquez, Carlos
A1 Leco Berrocal, María Isabel
A1 Sáez Alcaide, Luis Miguel
A1 Meniz García, Cristina María
AB Objective: The aim of this study is to know the biological therapy drugs that are related to adverse events, what dental treatments are associated with the appearance of these events, their severity, and how they are resolved. Study design: Analysis of cases described in the literature on patients undergoing treatment with biological therapies who have developed adverse effects associated with these drugs. Results: Of the 62 articles reviewed, 49 describe 68 cases of MRONJ, most of which appeared in the jaw and received surgical and/or conservative treatment. Conclusions: Biological therapies can potentially develop adverse effects in the oral cavity, so strict monitoring by the dentist is necessary.
PB MDPI
SN 2076-3417
YR 2021
FD 2021
LK https://hdl.handle.net/20.500.14352/87273
UL https://hdl.handle.net/20.500.14352/87273
LA eng
NO Amigo-Basilio, M.; Álvarez-González, C.; Cobo-Vázquez, C.; Leco-Berrocal, I.; Sáez-Alcaide, L.M.; Méniz-García, C. Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies. Appl. Sci. 2021, 11, 4865. https://doi.org/10.3390/ app11114865
DS Docta Complutense
RD 16 abr 2025